U.S. High Growth Tech and AI Stocks

SELLAS Life Sciences Group

Market Cap: US$145.4m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Vericel

Market Cap: US$2.1b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

TriSalus Life Sciences

Market Cap: US$164.9m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics for improving outcomes for patients with difficult-to-treat liver and pancreatic cancers.

BioRestorative Therapies

Market Cap: US$12.5m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Krystal Biotech

Market Cap: US$3.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Commvault Systems

Market Cap: US$8.0b

Provides a platform that enhances cyber resiliency by protecting data and cloud-native applications in the United States and internationally.

CompoSecure

Market Cap: US$1.3b

Manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally.

Outlook Therapeutics

Market Cap: US$58.7m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

Vertex Pharmaceuticals

Market Cap: US$111.5b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Semrush Holdings

Market Cap: US$1.6b

Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.

Anavex Life Sciences

Market Cap: US$714.6m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

CleanSpark

Market Cap: US$2.6b

Operates as a bitcoin mining company in the Americas.

Mirum Pharmaceuticals

Market Cap: US$2.2b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Mereo BioPharma Group

Market Cap: US$346.6m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Amicus Therapeutics

Market Cap: US$1.8b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Savara

Market Cap: US$655.2m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Protalix BioTherapeutics

Market Cap: US$132.9m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Day One Biopharmaceuticals

Market Cap: US$624.4m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Bit Digital

Market Cap: US$494.2m

Engages in the bitcoin mining business.

ImmunityBio

Market Cap: US$2.4b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

ServiceNow

Market Cap: US$214.3b

Provides cloud-based solution for digital workflows in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally.

Take-Two Interactive Software

Market Cap: US$41.1b

Develops, publishes, and markets interactive entertainment solutions for consumers worldwide.

IREN

Market Cap: US$1.9b

Owns and operates bitcoin mining data centers.

Clene

Market Cap: US$23.2m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Corning

Market Cap: US$40.8b

Engages in the optical communications, display technologies, environmental technologies, specialty materials, and life sciences businesses in the United States and internationally.

Trade Desk

Market Cap: US$38.1b

Operates as a technology company in the United States and internationally.

Fennec Pharmaceuticals

Market Cap: US$188.9m

Operates as a commercial stage biopharmaceutical company in the United States.

Evaxion

Market Cap: US$11.0m

Evaxion Biotech A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Sierra Oncology

Market Cap: US$1.3b

Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.

AsiaFIN Holdings

Market Cap: US$44.9m

An investment holding company, primarily engages in the provision of market research studies and consultancy services to the payment solution industry in ASEAN countries, and internationally.

AmpliTech Group

Market Cap: US$38.9m

Designs, engineers, and assembles micro-wave component-based amplifiers.

Ultragenyx Pharmaceutical

Market Cap: US$3.3b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Canaan

Market Cap: US$283.9m

Engages in the research and development, design, and sale of integrated circuits (IC), and lease of final mining equipment by integrating IC products for bitcoin mining and related components in the People’s Republic of China.

Protagonist Therapeutics

Market Cap: US$2.8b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

GeoVax Labs

Market Cap: US$12.6m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

Zai Lab

Market Cap: US$3.1b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.